Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-F Riou

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 1, 1994
Control of somitic expression of tenascin in Xenopus embryos by myogenic factors and BrachyuryM Umbhauer, J F Riou, J C Smith, et al.
Biochemical Pharmacology|September 1, 1993
Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicinJ F Riou, L Grondard, O Petitgenet, et al.
Pathologie-Biologie|November 1, 1987
[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]M J Vilarem, J F Riou, G Riou, et al.
Biochemical Pharmacology|December 15, 1986
Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSAJ F Riou, M J Vilarem, C J Larsen, et al.
Biochemistry|April 8, 1986
Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavageJ F Riou, M Gabillot, M Philippe, et al.
Biochemistry|June 4, 1998
Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.
Mechanisms of Development|July 27, 2001
Cloning and developmental expression of STAT5 in Xenopus laevisA Pascal, J F Riou, C Carron, et al.
Seminars in Oncology|February 1, 1996
Preclinical evaluation of CPT-11 and its active metabolite SN-38F Lavelle, M C Bissery, S André, et al.
Biochimica Et Biophysica Acta|March 15, 1997
Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?I Chourpa, A Beljebbar, G D Sockalingum, et al.
International Journal of Oncology|March 17, 2001
RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cellsP Russo, C Ottoboni, A Crippa, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 1, 1994
Control of somitic expression of tenascin in Xenopus embryos by myogenic factors and BrachyuryM Umbhauer, J F Riou, J C Smith, et al.
Biochemical Pharmacology|September 1, 1993
Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicinJ F Riou, L Grondard, O Petitgenet, et al.
Pathologie-Biologie|November 1, 1987
[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]M J Vilarem, J F Riou, G Riou, et al.
Biochemical Pharmacology|December 15, 1986
Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSAJ F Riou, M J Vilarem, C J Larsen, et al.
Biochemistry|April 8, 1986
Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavageJ F Riou, M Gabillot, M Philippe, et al.
Biochemistry|June 4, 1998
Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.
Mechanisms of Development|July 27, 2001
Cloning and developmental expression of STAT5 in Xenopus laevisA Pascal, J F Riou, C Carron, et al.
Seminars in Oncology|February 1, 1996
Preclinical evaluation of CPT-11 and its active metabolite SN-38F Lavelle, M C Bissery, S André, et al.
Biochimica Et Biophysica Acta|March 15, 1997
Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?I Chourpa, A Beljebbar, G D Sockalingum, et al.
International Journal of Oncology|March 17, 2001
RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cellsP Russo, C Ottoboni, A Crippa, et al.
Pageof 11